
Rockville cancer diagnostics company 20/20 Gene Systems Inc. recently completed a $4.5 million Series A equity funding round led by the venture capital division of China’s largest insurance company, Ping An Ventures.

Rockville cancer diagnostics company 20/20 Gene Systems Inc. recently completed a $4.5 million Series A equity funding round led by the venture capital division of China’s largest insurance company, Ping An Ventures.
![]()
On February 8, 2016, the National Institute of Standards and Technology hosted a ribbon cutting and building dedication ceremony for the National Cybersecurity Center of Excellence’s (NCCoE) new facility in Rockville, Md.
Representing the public-private collaboration at the center, Commerce Secretary Penny Pritzker, Senator Barbara Mikulski, Senator Ben Cardin, Rep. John Delaney, Rep. John Sarbanes, Maryland Lt. Governor Boyd Rutherford, Montgomery County Executive Ike Leggett, and Under Secretary of Commerce for Standards and Technology and NIST Director Willie May participated in the ribbon cutting.

The Maryland Technology Development Corporation’s (TEDCO) core research, technology transfer, and commercialization programs generated nearly $1 billion in economic contributions to the Maryland economy in 2015, according to a new study by the Battelle Technology Partnership Practice released today. Battelle, the world’s largest non-profit research and development organization, also found that TEDCO’s efforts generated a total of 4,358 high-quality jobs, with an average income per job of $74,700. That compares favorably to a statewide average labor income per worker of $63,700.

The Ewing Marion Kauffman Foundation today announced the appointment of Victor W. Hwang as vice president of entrepreneurship. Hwang will relocate from California to Kansas City to lead the Foundation’s renowned entrepreneurship programming. He starts on Feb. 29.

The median pay among STEM workers in 2014 was more than $72,000. That’s more than double the median income among all occupations, according to Bureau of Labor Statistics data. Few would argue, however, that STEM workers are generally overpaid. Experts in the fields of science, technology, engineering and math are key contributors to economic growth. Furthermore, STEM occupations generally require years of rigorous and difficult training.

I’m not sure about you, but I’m getting tired of Steve Jobs. Sure, he was an innovation icon. But, in my view, the media and pundits are creating unrealistic expectations hyping and promoting the Jobs/Branson/Musk iconography.

Yumanity Therapeutics, a drug developer focused on diseases caused by protein misfolding, has raised $45 million in Series A funding. Fidelity Management & Research Company led the round with participation from Redmile Group, Alexandria Venture Investments, Biogen, Sanofi-Genzyme BioVentures and Dolby Family Ventures.

Bobby Gattuso became a startup founder while an undergraduate at Towson University.
Hop Theory’s sachets that bring beer up to craft levels got early traction through Kickstarter and national press hits.

A senior Google executive, Jeff Huber, will become the CEO of Grail, the high-profile company launched in January to develop and commercialize cancer blood tests.
According to Forbes, Huber’s wife, Laura, died from colon cancer last November, leaving behind two teenage children. “That’s a big part of why I’m taking this up,” Huber told the magazine.

“You are cordially invited to the “SBIR and STTR Federal Funding Mechanisms for Improving the Reach of Behavioral Science” seminar at the Society of Behavioral Medicine (SBM) 2016 Annual Meeting & Scientific Sessions. National Cancer Institute SBIR (NCI SBIR) Development Center Program Director Dr. Patricia Weber will be leading the seminar with presenters from NIH, including NCI and NHLBI, a HealthTech investment CEO and a small business entrepreneur. The session will include a range of topics such as an overview of the SBIR/STTR program goals, how NCI and NHLBI work to help with the commercialization process, how SBIR/STTR funding can advance behavioral science, investor perspectives on behavioral health products, and perspectives from an awardee.”